Dr. Joy Marla Gelbman, MD

Dr. Gelbman practices at Weill Medical College of Cornell University in New York, New York.

Dr. Gelbman's NPI, 1003868696, was assigned on May 16, 2006. Dr. Gelbman graduated from Johns Hopkins University School of Medicine in 2000. Dr. Gelbman holds New York license 223517.

Dr. Gelbman's primary practice is Weill Medical College of Cornell University, at 1305 York Ave, New York, NY 10021 in New York County. The practice phone is (646) 962-5483.

Dr. Gelbman's primary practice is Weill Medical College of Cornell University in New York, New York. Dr. Gelbman is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Gelbman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gelbman practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gelbman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Gelbman is licensed in New York.

Dmand AI lists aneurysm, aortic atherosclerois, atrial fibrillation and flutter, cardiomyopathy, cerebrovascular disease, chronic hypertension, circulation problems and coronary artery disease among the conditions Dr. Gelbman treats.

CMS data shows 1,949 Medicare services from Dr. Gelbman across 8 procedure codes in 2024, for 783 Medicare patients. Medicare paid $120,042 for them.

CMS counts 783 Medicare patients who saw Dr. Gelbman in 2024. The largest group is 75 to 84, with 331 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gelbman's median patient age at 65, with 62% women.

In 2024, Dr. Gelbman wrote 2,863 Medicare Part D claims for 651 patients. 89% of them were for generic drugs. CMS names the drug for 2,607 of them, across 31 drugs with 11 or more claims each, at $314,169 in total drug cost. In 2023, CMS named 4,215 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gelbman for performance year 2024, reported through an alternative payment model (APM). Dr. Gelbman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gelbman as offering telehealth.

Dmand AI links 1 paper to Dr. Gelbman.

CMS Open Payments shows 2 general payments to Dr. Gelbman from 2 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $181.

Dmand AI lists 1 award for Dr. Gelbman, most recently CMS Stage 1 EHR in 2013.

Dr. Gelbman graduated from Johns Hopkins University School of Medicine in 2000.

Dr. Gelbman is in network with 16 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.